Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updates

Context Several phase III randomized controlled trials (RCTs) have shown the importance of perioperative systemic therapy, especially for the efficacy of immune checkpoint inhibitors (ICIs) in both neoadjuvant and adjuvant settings for muscle-invasive bladder cancer (MIBC). Objective To synthesize t...

Descripció completa

Dades bibliogràfiques

Autors principals:	Takafumi Yanagisawa, Akihiro Matsukawa, Jeremy Yuen-Chun Teoh, Keiichiro Mori, Tatsushi Kawada, Satoshi Katayama, Paweł Rajwa, Fahad Quhal, Benjamin Pradere, Marco Moschini, Shahrokh F. Shariat, Jun Miki, Takahiro Kimura
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2025-03-01
Col·lecció:	Bladder Cancer
Accés en línia:	https://doi.org/10.1177/23523735251335122
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!